![Cbd Vs Hemp Gummies: Which Is Right For Your Wellness Routine? [Tz8JKLqMk37]](https://cedclinic.com/wp-content/uploads/2026/07/ced-pexels-5021600-150x150.jpg "Cbd Vs Hemp Gummies: Which Is Right For Your Wellness Routine? [Tz8JKLqMk37] 4")
Policy Watch: 20 Regulatory Updates — March 20, 2026
This update covers drug enforcement controlled substances regulatory policy changes relevant to cannabis clinicians. It highlights new scheduling of synthetic cannabinoids and benzodiazepine analogs. Clinicians should stay informed on these regulatory…
Policy Watch: 10 Regulatory Updates — March 18, 2026
This Policy Watch covers the DEA marijuana rescheduling 2026 proposal and other key regulatory updates affecting cannabis clinicians. The rescheduling could facilitate research and patient access by acknowledging medical utility. These regulatory changes…
Policy Watch: 27 Regulatory Updates — March 16, 2026
Policy WatchMarch 16, 2026. 27 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Federal RegisterSchedules of…
AM Policy Update: DEA Scheduling and Cannabis Rescheduling March 16, 2026
The DEA scheduling cannabis rescheduling update on March 16, 2026, highlights key regulatory changes affecting cannabis medicine. This includes the temporary placement of several substances in Schedule I and the proposed rescheduling of marijuana. These…
Policy Watch: 25 Regulatory Updates — March 12, 2026
The March 12, 2026 update covers DEA scheduling synthetic drugs and related regulatory affairs. This includes synthetic opioids and marijuana rescheduling proposals. Clinicians should note implications for controlled substances management.